Skip to main content
Timothy Ley, MD, Hematology, Saint Louis, MO

TimothyJLeyMD

Hematology Saint Louis, MO

Hematologic Oncology, Sickle Cell & Other Anemias

Professor of Medicine

Dr. Ley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ley's full profile

Already have an account?

  • Office

    1 Barnes Jewish Hospital Plz
    # Div
    Saint Louis, MO 63110
    Phone+1 314-362-8831
    Fax+1 314-362-9333

Summary

  • Dr. Timothy Ley is a hematologist based in Saint Louis, MO, specializing in hematologic oncology, and diseases such as sickle cell anemia. He completed his medical education at Washington University in St. Louis School of Medicine and further training at Massachusetts General Hospital and the National Institutes of Health. Dr. Ley has been a professor at Washington University since 1986 and has significant experience in areas like acute myeloid leukemia and computational biology. His research has been published in prominent journals such as the New England Journal of Medicine and Nature. Dr. Ley has led clinical trials on genomic predictors in hematologic diseases and has been recognized with numerous honors, including election to the National Academy of Sciences, the National Academy of Medicine, and the American Academy of Arts and Sciences.

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1983 - 1984
  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1980 - 1983
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1979 - 1980
  • Massachusetts General Hospital
    Massachusetts General HospitalInternship, Internal Medicine, 1978 - 1979
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1978, MD
  • Drake University
    Drake UniversityBA, Biology, 1971 - 1974

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 1986 - 2026
  • MD State Medical License
    MD State Medical License 1981 - 1986
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Elected National Academy of Sciences, 2019
  • Elected American Academy of Arts and Sciences, 2010
  • Elected National Academy of Medicine, 2003
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Differences in human ?, ?, and ?-globin gene expression in monkey kidney cells.  
    Humphries, R.K., Ley, T.J., Turner, P., Moulton, A.D., and Nienhuis, A.W, Cell 30:173-183
  • RNA processing errors in patients with ? thalassemia.  
    Ley, T.J., Anagnou, N., Pepe, G., and Nienhuis, and A.W, Proc. Natl. Acad. Sci. USA 79:4775-4779
  • Spontaneous subarachnoid hemorrhage simulating acute transmural myocardial infarction.  
    Gascon, P., Ley, T., Toltzis, R., and Bonow, R, Am. Heart J. 105:511-513
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • The Molecular Basis of Long First Remissions in Normal Karyotype AML Patients
    Timothy J Ley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Whole Genome Bisulfite Sequencing of 63 Primary AML Samples Identifies a Unique DNA Hypermethylation Signature for Mutant IDH1/2 Cases That Is Different from That of T...
    Timothy J Ley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Gata2 Expression and Function in PML-RARA-driven Preleukemia and APL
    Timothy J Ley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Evidence for Complete Mutation Clearance in Normal Karyotype AML Patients with Very Long (> 5 years) Remissions after Chemotherapy Alone 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Direct Detection of Expressed Mutations in AML Cells Using Single Cell RNA-Sequencing, and Its Impact on Defining Sources of Expression Heterogeneity 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Basic Science Symposium on AML Genomics. 
    American Society of Hematology
  • Join now to see all

Press Mentions

  • Birthplace of Precision Medicine
    Birthplace of Precision MedicineNovember 14th, 2024
  • Colonna, Ley Elected to National Academy of Sciences – WashU Medicine
    Colonna, Ley Elected to National Academy of Sciences – WashU MedicineNovember 12th, 2024
  • Serendipity Unites Physicians, Researchers, Families to Fight Rare Genetic Disease in Kids
    Serendipity Unites Physicians, Researchers, Families to Fight Rare Genetic Disease in KidsMarch 24th, 2022
  • Join now to see all

Grant Support

  • Genomics Of Acute Myelogenous Leukemia (Aml): Somatic Mutations &ConsequencesNational Cancer Institute2008–2012
  • AdministrationNational Cancer Institute2008–2012
  • The Biology Of Promyelocytic Leukemia In A Mouse ModelNational Cancer Institute2005–2012
  • Genomics Of Acute Myelogenous LeukemiaNational Cancer Institute2003–2012
  • Dmnt3a Mutations In Patients With Acute Myeloid LeukemiaNational Center For Research Resources2011
  • DNMT3A Mutations In Acute Myeloid LeukemiaNational Cancer Institute2011
  • Embryonic Stem Cell CoreNational Cancer Institute2010–2011
  • Regulation Of Fetal And Adult Human Hemoglobin ProductionNational Institute Of Diabetes And Digestive And Kidney Diseases2010
  • Genomics Of AML: Whole Genome ResequencingNational Cancer Institute2010
  • Genomics Of Acute Myelogenous Leukemia (2po1ca101937-06)National Cancer Institute2010
  • Role Of Granzymes In Cytotoxic Lymphocyte FunctionsNational Center For Research Resources2008–2010
  • Role Of Granzymes In Cytotoxic Lymphocyte FunctionsNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
  • Regulation Of Fetal And Adult Human Hemoglobin ProdNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2008
  • Core--Embryonic Stem Cell FacilityNational Cancer Institute2004–2008
  • Hematopoietic Development And Malignancy ProgramNational Cancer Institute2004
  • The Role Of Granzymes In Cytotoxic Lymphocyte FunctionsNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2004
  • The Biology Of Promyelocytic Leukemia In A Mouse MODEL.National Cancer Institute2000–2004
  • Regulation Of Fetal And Adult Human Hemoglobin ProductiNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2003
  • Stem Cell BiologyNational Cancer Institute2001–2002
  • Core--Embryonic Stem CellNational Cancer Institute2001–2002
  • Fetal And Adult Human Hemoglobin ProductionNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2000
  • Gene Regulation In Normal And Transformed CellsNational Cancer Institute1999
  • Regulation Of Human Cathepsin G Gene In Normal And Leukemic Blood CellsNational Cancer Institute1997–1999
  • Core--Embryonic Stem CellsNational Cancer Institute1997–1999
  • Granzymes And Cytotoxic Lymphocyte FunctionsNational Institute Of Diabetes And Digestive And Kidney Diseases1995–1999
  • Regulation Of HemoglobinNational Institute Of Diabetes And Digestive And Kidney Diseases1997–1998
  • Regulation Of HemoglobinNational Institute Of Diabetes And Digestive And Kidney Diseases1996
  • Regulation Of Hemoglobin ProductionNational Institute Of Diabetes And Digestive And Kidney Diseases1995
  • Regulation Of Hemoglobin ProductionNational Institute Of Diabetes And Digestive And Kidney Diseases1994
  • Regulation Of Fetal &Adult Human Hemoglobin ProductionNational Institute Of Diabetes And Digestive And Kidney Diseases1987–1993